Author

J.J. Sramek

Observed names: J J Sramek, J SRAMEK, J Sramek, J. J. Sramek, JJ Sramek

Observed institutions: Roger Williams Medical Center, Clinical Trials of Texas, Novartis (United States), University of Kansas Medical Center, Boehringer Ingelheim (United States), Clinical Trials Ontario

OpenAlex ID: A5108637034

Pramipexole in Patients with Early Parkinsonʼs Disease

1995 · J. P. Hubble, W. C. Koller, et al. · Clinical Neuropharmacology · 146

Pilot Study of MK-462 in Migraine

1996 · NR Cutler, J Claghorn, et al. · Cephalalgia · 35

Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacin

1997 · N R Cutler, J Vincent, et al. · Antimicrobial Agents and Chemotherapy · 30

Pharmacokinetics of co‐administered didanosine and stavudine in HIV‐ seropositive male patients.

1994 · RD Seifert, MB Stewart, et al. · British Journal of Clinical Pharmacology · 25

PDF

Oral Sumatriptan in Pharmacokinetics in the Migrainous State

1991 · NR Cutler, EK Hussey, et al. · Cephalalgia · 20

The utility of salivary amylase as an evaluation of M3 muscarinic agonist activity in alzheimer's disease

1995 · J Sramek · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 19

Effect of lithium on leukocytes: a two-year follow-up.

1983 · E H Pi, J J Sramek, et al. · PubMed · 16

Control of bed-wetting with benztropine

1990 · J F Costa, J Sramek, et al. · American Journal of Psychiatry · 8

Xanomeline, A Specific M1 Agonist: Early Clinical Studies

1994 · N. C. Bodick, A. F. DeLong, et al. · Birkhäuser Boston eBooks · 7

A Double-Blind, Randomized, Crossover Assessment of Blood Pressure Following Administration of Avitriptan, Sumatriptan, Or Placebo To Patients with Mild To Moderate Hypertension

1999 · SS Jhee, DE Salazar, et al. · Cephalalgia · 5

Exploratory studies: implications for drug development in Alzheimer's disease.

1998 · N R Cutler, J J Sramek · PubMed · 5

Assessing the neuropsychological profile of stable schizophrenic outpatients

1996 · N R Cutler, A E Veroff, et al. · Journal of Neuropsychiatry · 5

529. Pharmacokinetics of rivastigmine and its metabolite in patients with Alzheimer’s disease

2000 · N.R. Cutler, M. Hossain, et al. · Biological Psychiatry · 4

528. Antiemetics mitigate nausea and vomiting in Alzheimer’s patients receiving rivastigmine

2000 · N.R. Cutler, R.D. Hartman, et al. · Biological Psychiatry · 4

Placebo-controlled study of a CCKB antagonist in patients with panic disorder

1994 · N.R. Cutler, J.J. Sramek, et al. · Biological Psychiatry · 3

Dosing practices for high- and low-potency neuroleptics

1988 · G Hayes, J Sramek · American Journal of Psychiatry · 3

Maximally tolerated dose of the muscarinic agonist CI-979 in Alzheimer's disease (AD)

1994 · N.R. Cutler, J.J. Sramek, et al. · Biological Psychiatry · 2

Safety, tolerance, pharmacokinetic and RBC cholinesterase activity of MDL 73,745

1994 · N.R. Cutler, R.D. Seifert, et al. · Biological Psychiatry · 2

157. NXX-066 in patients with Alzheimer's disease: A bridging study

1998 · N.R. Cutler, G. Friday, et al. · Biological Psychiatry · 1

Pharmacokinetics (PK) of BMS-180048 in migraine patients.

1996 · I.E. Fulmor, N.R. Cutler, et al. · Clinical Pharmacology & Therapeutics · 1

MK-462 in migraine: A pilot study.

1996 · N.R. Cutler, J. Claghorn, et al. · Clinical Pharmacology & Therapeutics · 1

P-8-10 Safety and tolerance of ENA 713 in Alzheimer's disease (AD)

1995 · N.R. Cutler, J.J. Sramek, et al. · European Neuropsychopharmacology · 1

Tolerability and pharmacodynamics of besipirdine in Alzheimer's disease

1995 · N.R. Cutler, J.J. Sramek, et al. · Biological Psychiatry · 1

A bridging study of xanomeline tartrate in Alzheimer's disease (AD)

1994 · N.R. Cutler, J.J. Sramek, et al. · Biological Psychiatry · 1

156. The maximum tolerated dose (MTD) of metrifonate in Alzheimer's patients

1998 · N.R. Cutler, P. Cyrus, et al. · Biological Psychiatry

Works count: 37

Citation count: 345

H-index: 8

I10-index: 7